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Edited by Hans-Dieter KlenkAbstract The West Nile virus (WNV) RNA genome harbors
the characteristic methylated cap structure present at the 5 0
end of eukaryotic mRNAs. In the present study, we report a de-
tailed study of the binding energetics and thermodynamic param-
eters involved in the interaction between RNA and the WNV
RNA triphosphatase, an enzyme involved in the synthesis of
the RNA cap structure. Fluorescence spectroscopy assays re-
vealed that the initial interaction between RNA and the enzyme
is characterized by a high enthalpy of association and that the
minimal RNA binding site of NS3 is 13 nucleotides. In order
to provide insight into the relationship between the enzyme struc-
ture and RNA binding, we also correlated the eﬀect of RNA
binding on protein structure using both circular dichroism and
denaturation studies as structural indicators. Our data indicate
that the protein undergoes structural modiﬁcations upon RNA
binding, although the interaction does not signiﬁcantly modify
the stability of the protein.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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West Nile virus (WNV) is a mosquito-borne virus that pri-
marily infects birds but occasionally also infects humans and
horses [1,2]. In humans, the most serious manifestation of
WNV infection is a fatal inﬂammation of the brain [3]. The fre-
quency of WNV outbreaks in humans has increased in recent
years, and the geographical distribution of WNV has expanded
to the Western hemisphere in 1999 [4]. Since then, the virus has
spread rapidly throughout North America and has recently
reached the European continent [5]. The lack of vaccines or
therapeutic treatments for WNV infections has therefore
prompted the elaboration of extensive prevention strategies.
WNV is a member of the Flaviviridae family which includes
more than 70 human pathogens such as hepatitis C, yellow fe-
ver, and Dengue fever viruses [6]. The ﬂaviviral genome is a
single-stranded RNA of positive polarity containing a single
open reading frame of about 11 kb in length [7,8]. This
RNA encodes for a large polyprotein precursor that is further
processed into three structural and seven non-structural pro-*Corresponding author. Fax: +1 819 564 5340.
E-mail address: martin.bisaillon@usherbrooke.ca (M. Bisaillon).
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doi:10.1016/j.febslet.2006.01.006teins [9,10]. The non-structural protein 3, NS3, is a multifunc-
tional protein that displays several distinct enzymatic
functions. The N-terminal domain of the protein harbors a ser-
ine protease activity which is involved in the proteolytic cleav-
age of the viral polyprotein precursor [11]. The C-terminal
domain of NS3 has been shown to possess both nucleoside tri-
phosphatase (NTPase) and helicase activities [12]. Finally, an
RNA triphosphatase activity has previously been reported
for a 50 kDa C-terminal region of the WNV NS3 protein re-
leased with subtilisin from the membranes of infected cells [13].
The WNV RNA genome harbors the characteristic methyl-
ated cap structure present at the 5 0 end of eukaryotic mRNAs
[14]. This structure, m7GpppN-, has been shown to play critical
roles both in translation and mRNA stability [15,16]. The
RNA cap structure is formed co-transcriptionally by three
sequential enzymatic reactions catalyzed by an RNA 5 0 tri-
phosphate, an RNA guanylyltransferase, and an RNA (guan-
ine-N7)methyltransferase. The importance of the cap structure
for RNA metabolism is underscored by genetic analyses in
Saccharomyces cerevisiae where it has been shown that the tri-
phosphatase, guanylyltransferase and methyltransferase com-
ponents of the capping apparatus are essential for cell
viability [17–22].
Although the RNA cap structures originating from viral and
cellular enzymes are often identical, the physical organization
of the genes, subunit composition, structure, and catalytic
mechanisms of the known virus-encoded mRNA capping en-
zymes are signiﬁcantly diﬀerent from those of metazoan host
cells [16]. Of particular interest is the RNA triphosphatase com-
ponent of the capping apparatus, which is both structurally and
mechanistically diﬀerent in mammalian cells. As a consequence
these viral cap-forming enzymes, such as the WNV NS3 pro-
tein, are attractive targets for antiviral drugs that would inter-
fere with the capping of pathogen mRNAs while leaving the
host capping enzymes unaﬀected. Two distinct families of
RNA triphosphatases have been clearly established so far.
The ﬁrst family includes enzymes from metazoan and plants
which belong to the cysteine phosphatases superfamily. These
proteins contain a characteristic HCXXXXXR(S/T) motif,
and act via the formation of a covalent enzyme-(cysteinyl-S-)-
phosphate intermediate [22,23]. Their enzymatic activity is
independent from divalent cations. Moreover, crystal structure
analyses suggest that they share a phosphate binding loop and a
core tertiary structure with other cysteine phosphatases [24].
The second family comprises RNA triphosphatases from
DNA viruses, fungus, and protozoan [22,25–28]. These en-
zymes require divalent cations for their enzymatic activity
and share characteristic conserved elements. Furthermore, they
also possess the ability to hydrolyze NTPs. Crystal structure
analyses of the yeast RNA triphosphatase have revealed a un-blished by Elsevier B.V. All rights reserved.
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forms a topologically closed tunnel [29]. Interestingly, RNA tri-
phosphatases from RNA viruses belonging to the Alphaviridae,
Reoviridae, and Flaviviridae families appear to lack any resem-
blance to enzymes from the two classical RNA triphosphatase
families [13,30–33]. It is thought that the active site of the RNA
triphosphatases from RNA viruses might share elements with
the helicase/NTPase catalytic center.
As a ﬁrst step towards elucidating the nature of the speciﬁc
interaction between RNA and the WNV RNA triphosphatase,
we have utilized ﬂuorescence spectroscopy to precisely monitor
the energetics of RNA binding to the enzyme. We report a de-
tailed study of the binding kinetics and thermodynamic param-
eters involved in the interaction between RNA and the NS3
protein. Using circular dichroism, we also investigated the ef-
fect of RNA binding on both the structure and stability of
the protein. Finally, we developed a three-dimensional model
of the WNV NS3 protein based on the crystal structure of re-
lated proteins from other ﬂaviviruses. We believe that such
quantitative analyses, and provide crucial insights on the inter-
action between RNA and RNA triphosphatases.2. Materials and methods
2.1. cDNA synthesis and cloning
AcDNA fragment covering the C-terminal region of theWNV (strain
NY99)NS3 genewas synthesized fromgenomicWNVRNA(a generous
gift of Dr. Hugues Charest) through reverse-transcription (RT)-PCR
according to the manufacturer’s instructions (Qiagen) using the primers
5 0-GGCTCATACATAAGCGCGATACATATGGGTGAAAGGA-
TGGATGAGCCA-30 and 5 0-CAGAACCTCAATGAGCCCGGAT-
CCTTAACGTTTTCCCGAGGCGAAGTC-30. These primers were
used to generate an NdeI site and a BamHI site ﬂanking the 3 0 region
of the WNV NS3 gene. The generated cDNA corresponds to the
5486–6495 nucleotide region segment of theWNVgenome strainNY99.
2.2. Expression and puriﬁcation of the recombinant NS3 protein
A plasmid for the expression of a truncated WNV NS3 protein was
generated by inserting a truncated version of the WNV NS3 gene,
encompassing amino acid residues 168–618, between the NdeI and
BamHI cloning sites of the pET28a expression plasmid (Novagen).
In this context, the truncated NS3 protein is fused in frame with an
N-terminal peptide containing 6 tandem histidine residues, and expres-
sion of the His-tagged protein is driven by a T7 RNA polymerase pro-
moter. The resulting recombinant plasmid (pET-NS3D167) was
transformed into Escherichia coli BL21(DE3) and a 1000-ml culture
of E. coli BL21(DE3)/pET-NS3D166 was grown at 37 C in Luria-Ber-
tani medium containing 30 lg/ml of kanamycin until the A600 reached
0.5. The culture was adjusted to 0.4 mM isopropyl-b-D-thiogalactopy-
ranoside (IPTG) and the incubation continued at 18 C for 20 h in the
presence of 2% ethanol. The cells were then harvested by centrifuga-
tion, and the pellet stored at 80 C. All subsequent procedures were
performed at 4 C. Thawed bacteria pellets were resuspended in 5 ml of
lysis buﬀer A (50 mM Tris–HCl, pH 7.5, 150 mM NaCl, and 10% su-
crose) and cell lysis achieved by the addition of lysozyme and Triton
X-100 to ﬁnal concentrations of 50 lg/ml and 0.1%, respectively. The
lysates were sonicated to reduce viscosity, and any insoluble material
removed by centrifugation at 13000 rpm for 45 min. The soluble ex-
tract was applied to a 3-ml column of Ni-nitrilotriacetic acid-agarose
(Qiagen) that had been equilibrated with buﬀer A containing 0.1% Tri-
ton X-100. The column was washed with buﬀer A containing 5 mM
imidazole, and then eluted stepwise with buﬀer B (50 mM Tris–HCl,
pH 8.0, 0.1 M NaCl, and 10% glycerol) containing 50, 100, 200, 500,
and 1000 mM imidazole. The polypeptide composition of the column
fractions was monitored by sodium dodecyl sulfate (SDS)–polyacryl-
amide gel electrophoresis (PAGE). The recombinant NS3 protein
was retained on the column and recovered predominantly in the
200 mM imidazole eluate. The eluate was applied to a 3-ml columnof phosphocellulose that had been equilibrated in buﬀer C (50 mM
Tris–HCl, pH 8.0, 50 mM NaCl, and 10% glycerol). The column was
washed with the same buﬀer, and then eluted stepwise with buﬀer C
containing 0.1, 0.2, 0.3, 0.4, 0.5, and 1.0 M NaCl. The recombinant
protein was retained on the column and was recovered in both the
0.5 M and 1.0 M NaCl fractions. Following dialysis against buﬀer C,
the phosphocellulose preparation was stored at 80 C. Protein con-
centration was determined by the Bradford dye binding method using
bovine serum albumin as the standard.
2.3. Preparation of the RNA triphosphatase substrate
An RNA substrate of 84 nucleotides was synthesized with the MAX-
Iscript kit (Ambion) using T7 RNA polymerase and [c-32P]GTP. The
RNA transcript was synthesized from the pBS-KSII+ plasmid (Strat-
agene) that had been linearized with HindIII. The RNA substrate
was puriﬁed on a denaturing 10% polyacrylamide gel and visualized
by ultraviolet shadowing. The corresponding band was excised, and
then eluted from the gel by an overnight incubation in 0.1% SDS/
0.5 M ammonium acetate. The RNA was then precipitated with etha-
nol and quantitated by spectrophotometry.
2.4. RNA triphosphatase assay
Reaction mixtures (20 ll) containing 50 mM Tris–HCl, pH 7.5,
5 mM DTT, 0.9 lM of the RNA substrate radiolabeled at its terminal
c-phosphate, and various concentrations of enzyme (as indicated) were
incubated for 60 min at 37 C. The reactions were quenched by adding
2 ll of 5 M formic acid. Aliquots of the mixtures were applied to a
polyethyleneimine-cellulose TLC plate, which was developed with
0.75 M potassium phosphate, pH 4.3. The release of 32Pi was quanti-
tated by scanning the TLC plate with a phosphorimager.
2.5. Synthetic RNAs
RNA molecules of various lengths were obtained from Integrated
DNA Technologies (Coralville, Iowa). The 5 0 hydroxy-terminated
RNAs were quantiﬁed by spectrophotometry at 260 nm.
2.6. Fluorescence measurements
Fluorescence was measured using an Hitachi F-2500 ﬂuorescence
spectrophotometer. Excitation was performed at a wavelength of
290 nm. Background emission was eliminated by subtracting the signal
from either buﬀer alone or buﬀer containing the appropriate quantity
of substrate.
The extent to which RNA binds to the WNV NS3 protein was deter-
mined by monitoring the ﬂuorescence emission of a ﬁxed concentration
of proteins and titrating with a given ligand. The binding can be de-
scribed by
Kd ¼ ½NS3½RNA½NS3 RNA ð1Þ
where Kd is the apparent dissociation constant, [NS3] is the concentra-
tion of the protein, [NS3 Æ RNA] is the concentration of complexed
protein, and [RNA] is the concentration of unbound RNA.
The proportion of RNA-bound protein as described by Eq. (1) is re-
lated to measured ﬂuorescence emission intensity by
DF =DF max ¼ ½NS3 RNA=½NS3tot ð2Þ
where DF is the magnitude of the diﬀerence between the observed ﬂuo-
rescence intensity at a given concentration of RNA and the ﬂuores-
cence intensity in the absence of RNA, DFmax is the diﬀerence at
inﬁnite [RNA], and [NS3]tot is the total protein concentration.
If the total RNA concentration, [RNA]tot, is in large molar excess rel-
ative to [NS3]tot, then it can be assumed that [RNA] is approximately
equal to [RNA]tot. Eqs. (1) and (2) can then be combined to give
DF =DF max ¼ ½RNAtot=ðKd þ ½RNAtotÞ ð3Þ
The Kd values were determined from a non-linear least square regres-
sion analysis of titration data by using Eq. (3).
2.7. Electrophoretic mobility shift assays
An electrophoretic mobility shift assay was used to measure the
binding of the WNV NS3 protein to RNA. A radiolabeled RNA sub-
strate of 84 nucleotides was synthesized by in vitro transcription using
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[a-32P]UTP. The RNA transcript was synthesized from the pBS-KSII+
plasmid (Stratagene), which had been linearized with HindIII. The
RNA substrate was puriﬁed on a denaturing 10% polyacrylamide gel
and visualized by UV shadowing. The corresponding band was excised
and then eluted from the gel by an overnight incubation in 0.1% SDS/
0.5 M ammonium acetate. The RNA was then precipitated with etha-
nol and quantiﬁed by spectrophotometry.
The standard binding reaction was performed in a buﬀer containing
10 mM Tris–HCl, pH 7.5, 10 mM NaCl, and incubated for 30 min at
25 C. The binding reaction mixtures were directly subjected to electro-
phoresis on 10% polyacrylamide gels, and the bands were visualized by
autoradiography. The extent of binding was quantitated by scanning
the gel with a PhosphorImager (Amersham Biosciences). The apparent
dissociation constant (Kd) for RNA was determined according to
fD ¼ ½NS3Kd þ ½NS3 ð4Þ
where fD represents the fraction of the shifted nucleic acids, [NS3] is
the total protein concentration, and Kd is the dissociation constant
for the binding reaction.
2.8. Circular dichroism spectroscopy measurements
Circular dichroism (CD) measurements were performed with a Jasco
J-810 spectropolarimeter. The samples were analyzed in quartz cells
with pathlengths of 1 mm. Far-UV and near-UV wavelength scans
were recorded from 200 to 250 nm and from 250 to 340 nm, respec-
tively. All the CD spectra were corrected by subtraction of the back-
ground for the spectrum obtained with either buﬀer alone or buﬀer
containing the ligand. The average of 3 wavelength scans is presented.
The ellipticity results were expressed as mean residue ellipticity, [h], in
degrees cm2 dmol1.
2.9. Thermal unfolding experiments
Thermal denaturations were monitored by following the change in
CD ellipticity of the NS3 protein (5 lM) at 222 nm. The samples were
heated from 5 to 110 C, at a heating rate of 1 C/min. The ellipticity
results were expressed as mean residue ellipticity, [h], in
degrees cm2 dmol1. The fraction of unfolded protein at each temper-
ature was determined by calculating the ratio [h222]/[h222]d, where
[h222]d is the molar ellipticity for the completely unfolded enzyme.
2.10. ANS binding measurements
Binding of ANS (1-anilino-8-naphtalenesulfonate) was evaluated by
measuring the ﬂuorescence enhancement of ANS (50 lM) upon excita-
tion at a wavelength of 380 nm. The emission spectra were integrated
from 400 to 600 nm.
2.11. Homology modeling
The crystal structure of the Hepatitis C virus NS3 protein was used
as a template to model the WNV NS3 protein. The atomic coordinates
were obtained from the Protein Data Bank ﬁle 1A1V, representing the
crystal structure of the complex between the HCV NS3 protein and a
synthetic oligonucleotide. The predicted three-dimensional structure of
the WNV NS3 enzyme active site was generated with the Deep View
program [34].3. Results
3.1. Expression and puriﬁcation of the WNV NS3 protein
A cDNA encoding a truncated WNV version of the NS3
protein lacking the N-terminal protease domain (amino acids
1–166) was cloned into a T7 RNA polymerase-based vector
that allowed the addition of a 6-histidine tag. In order to char-
acterize the RNA triphosphatase activity of the enzyme, the
protein was expressed in bacteria and puriﬁed by sequential
nickel-agarose and phosphocellulose chromatography steps.
SDS–PAGE analysis revealed that the 53-kDa NS3 protein
(amino acids 167–618) was the predominant polypeptide inthe puriﬁed fraction (Fig. 1A). The concentration of NS3 pro-
tein in this fraction was estimated to be 11 lM. The enzymatic
characterization of the recombinant NS3 protein was per-
formed using this phosphocellulose fraction.
3.2. Characterization of the RNA triphosphatase activity
To directly assess if the recombinant WNV NS3 protein can
act as an RNA triphosphatase, an RNA substrate of 84 nucle-
otides labeled at its terminal c-phosphate was prepared by
in vitro transcription in the presence of [c-32P]GTP. The
RNA triphosphatase activity of the NS3 protein was then
gauged by the release of 32Pi from the radiolabeled-RNA.
The extent of phosphate hydrolysis during a 60 min incubation
at 37 C was proportional to input protein (Fig. 1B). An
apparent Km value of 3 lM was determined by a double-reci-
procal plot for the RNA substrate (Fig. 1C).
In order to gain additional insight into the NS3-associated
RNA 5-triphosphatase activity, the reaction requirements, op-
tima, and kinetic parameters were investigated. To determine
the divalent cation cofactor requirements of the enzymatic
activity, assays were performed in the presence of various
MgCl2 concentrations. The NS3 protein exhibited its maxi-
mum RNA triphosphatase activity in the absence of magne-
sium (Fig. 1D). Addition of magnesium ions resulted in a
concentration-dependent decrease of the phosphohydrolase
activity. The presence of 15 mMMgCl2 resulted in a 50% inhi-
bition of the NS3-mediated RNA triphosphatase activity
(Fig. 1D). Interestingly, the addition of manganese also re-
sulted in a decrease of the RNA triphosphatase activity. The
activity was inhibited by 50% in the presence of 1 mM MnCl2
(Fig. 1D). The presence of high concentrations of both cobalt
and calcium ions did not have any eﬀect on the NS3-mediated
RNA triphosphatase activity (data not shown). It should be
noted that the magnesium- and manganese-induced inhibition
are not related to an increase of the ionic strength of the reac-
tion buﬀer as revealed from the assays performed in the pres-
ence of increasing concentrations of KCl (Fig. 1E). RNA
triphosphatase assays performed in the presence of 15 mM
KCl only resulted in an inhibition of 20%.
The eﬀect of temperature on the RNA 5-triphosphatase was
also analyzed. The temperature optimum of the reaction, as
judged by the maximum rate of triphosphate-terminated
RNA hydrolysis, was 37 C (Fig. 1F). Reactions that were
incubated at 30 or 50 C resulted in a decrease of nearly 50%
of hydrolysis. Finally, the pH-dependence of the RNA triphos-
phatase reaction was analyzed (Fig. 1G). The hydrolysis of the
radiolabeled-RNA was shown to cover a wide pH-range from
6.0 to 9.0, with a pH optimum for the reaction at 7.0.
Because of its importance in the WNV replication cycle, the
NS3 protein represents an attractive target for the design and
development of small molecules inhibitors. Given that inor-
ganic phosphate is the product of the RNA triphosphatase
reaction, we surmised that phosphate derivatives might be eﬃ-
cient competitors and therefore served as the starting lead mol-
ecules for our inhibition studies. The addition of high
concentrations of inorganic phosphate did not lead to a de-
crease of the NS3-mediated phosphohydrolase reaction
(Fig. 1H). However, inorganic tripolyphosphate (PPPi) was a
very potent inhibitor, with 50% inhibition occurring at
0.7 lM PPPi (Fig. 1H). The Ki for this inhibition was calcu-
lated from the Cheng–Prusoﬀ equation [35] to be approxi-
mately 40 nM (data not shown).
Fig. 1. Expression, puriﬁcation, and RNA triphosphatase activity of recombinant WNV NS3 protein. (A) An aliquot (2 lg) of the puriﬁed
preparation of the NS3 protein was analyzed by electrophoresis through a 12.5% polyacrylamide gel containing 0.1% SDS and visualized by staining
with Coomassie Blue Dye. The positions and sizes (in kDa) of the size markers are indicated on the left. (B) Reaction mixtures containing an RNA
substrate radiolabeled at its terminal c-phosphate was incubated with the NS3 protein (25 nM) for 60 min at 37 C in a buﬀer containing 50 mM
Tris–HCl, pH 7.5, and 5 mM DTT. The reactions were quenched by adding 2 ll of 5 M formic acid. Aliquots of the mixtures were applied to a
polyethyleneimine-cellulose TLC plate, which was developed with 0.75 M potassium phosphate, pH 4.3. The release of 32Pi was quantitated by
scanning the TLC plate with a phosphorimager. The extent of phosphate release is plotted as a function of input protein. (C) Kinetic analysis of RNA
hydrolysis. The extent of phosphate release is plotted as a function of RNA concentration. A double-reciprocal plot of the data is shown in the right-
hand corner. (D) Standard RNA triphosphatase reactions were performed in the presence of magnesium (j) and manganese () metal ions. (E) The
eﬀect of increasing ionic strength on the RNA triphosphatase was investigated. Increasing concentrations of KCl were added to the reactions to
generate the desired ionic strength. (F) The eﬀect of temperature on the reaction was also analyzed. (G) NS3-mediated RNA triphosphatase reaction
as a function of pH. (H) Inhibition of the RNA triphosphatase activity by tripolyphosphate. Standard reactions were performed in the presence of
pyrophosphate (Pi) or tripolyphosphate (PPPi). The extents of hydrolysis were normalized to those of the control reactions for which no inhibitors
were included. The normalized activities are plotted as a function of the inhibitors concentrations.
870 I. Benzaghou et al. / FEBS Letters 580 (2006) 867–8773.3. Fluorescence properties of NS3
The binding of nucleic acids to free enzymes has previously
been shown to result in a signiﬁcant decrease in emission ﬂuo-
rescence intensities [36,37]. We initially sought to investigate
the binding of RNA to the WNV RNA triphosphatase by
titrating the binding of RNA to a ﬁxed concentration of the
NS3 protein. The ﬂuorescence emission spectrum of the puri-
ﬁed NS3 protein in standard buﬀer at 22 C is shown in
Fig. 2A. In order to obtain the maximal emission peak at
the low concentrations of protein required to accurately deter-
mine Kd values, excitation was carried out at 290 nm. Both
tyrosine and tryptophan absorb at this wavelength [38]. How-
ever, varying the excitation wavelength from 254 nm, where
the contribution of tyrosine ﬂuorescence to the emission spec-
trum would be the greatest, to 290 nm, where the emission
spectrum would arise almost exclusively from tryptophan, pro-
duced no change in the position of kmax (338 nm) or in the
spectral bandwidth (60 nm at half-height) (data not shown).
Thus, despite the fact that NS3 contains 11 tyrosines in addi-
tion to the 5 tryptophans, the emission spectrum is dominated
by the indole ﬂuorophores. This dominance is due, in part, to
the higher extinction coeﬃcient of tryptophan, and to reso-
nance energy transfer from tyrosine to tryptophan. The emis-
sion maximum of the enzyme (338 nm) is blue-shifted
relative to that of free L-tryptophan, which under the same
conditions is observed to be at 350 nm. The kmax of tryptophan
is highly sensitive to the polarity of the microenvironment inwhich its indole side chain is located. Blue shifts of protein
emission spectra have been ascribed to shielding of the trypto-
phan residues from the aqueous phase [39]. This shielding is
the result of the protein’s three-dimensional structure. Accord-
ingly, denaturation of NS3 with 8 M urea results in a red shift
of kmax towards 350 nm (Fig. 2A).
The molar intensity of the ﬂuorescence emission spectrum of
the WNV RNA triphosphatase was also evaluated. This spec-
trum was determined in order to see if signiﬁcant protein
aggregation, or if the loss of protein from solution through
adhesion, could inﬂuence the data. As can be seen in
Fig. 2B, a decrease in ﬂuorescence is observed with increasing
concentrations of NS3. A linear change of 3.6 ﬂuorescence
intensity units/nM of protein was observed over the range
examined. This relatively small change can be attributed to
minor aggregation occurring at higher protein concentrations.
Therefore, all the binding experiments were subsequently per-
formed at a protein concentration of 1 lM, with the assump-
tion that the binding equilibrium was not complicated by the
presence of an aggregation equilibrium.
3.4. RNA binding activity of NS3
Typical emission spectra obtained from the addition of
RNA to the NS3 protein are shown in Fig. 2C. We observed
that the binding of a 5 0 hydroxy-terminated 30-nt-long RNA
substrate to the enzyme resulted in a modiﬁcation of the inten-
sity of the intrinsic ﬂuorescence of the protein. The addition of
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Fig. 2. Titration of NS3 with RNA. (A) Background corrected ﬂuorescence emission spectra of NS3. 1, Puriﬁed protein in 50 mM Tris–HCl, and
50 mM KOAc, pH 7.5; 2, puriﬁed protein after a 1-h exposure to an 8 M solution of urea at 25 C. Fluorescence spectra were recorded at an
excitation wavelength of 290 nm. (B) Molar ﬂuorescence of NS3. Various concentrations of the puriﬁed NS3 protein were assayed in 50 mM Tris–
HCl, and 50 mM KOAc, pH 7.5. Emission was monitored at 338 nm and excitation was performed at 290 nm. (C) Increasing amounts of RNA were
added to a 1 lM solution of the enzyme in binding buﬀer (50 mM Tris–HCl and 50 mMKOAc, pH 7.5) and the emission spectrum was scanned from
310 to 440 nm upon excitation at 290 nm. (D) A saturation isotherm can be generated from these data by plotting the change in ﬂuorescence intensity
at 338 nm as a function of added RNA.
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in the ﬂuorescence intensity, however, both the emission max-
imum and spectral bandwidth were not signiﬁcantly aﬀected.
The corresponding saturation isotherm, generated by plotting
the change in ﬂuorescence intensity at 338 nm as a function of
added RNA, is shown in Fig. 2D. Quenching saturated at
micromolar RNA concentrations, and a 6 lM Kd value could
be estimated for the RNA substrate from a ﬁt of Eq. (1) to the
generated saturation isotherm. It should be noted that a simi-
lar binding constant was obtained using an electrophoretic
mobility shift assay with a triphosphate-terminated radiola-
beled RNA transcript of 84 nucleotides (data not shown)
thereby demonstrating that the nature of the 5 0 end of the
RNA substrate (hydroxy- or triphosphate-terminated) does
not inﬂuence the RNA binding ability of the protein.
About 37% of the intrinsic protein ﬂuorescence was accessi-
ble to the quencher RNA substrate (Fig. 2D). As a conse-
quence we were able to evaluate the Gibbs free energy of
binding (DG), as well a both the enthalpy (DH) and the entropy
changes (DS) associated with the binding of RNA to the en-
zyme. Evaluation of these thermodynamic parameters yields
important insight into the nature of the RNA binding reaction.Our binding studies indicate that the Gibbs free energy of
binding for the interaction of RNA with the enzyme was
29.8 kJ/mol. Although the free energy of binding provides
the overall description of the system, deﬁning the entropic
and enthalpic contributions to the free energy provides a more
complete understanding of the forces that drive the protein–
RNA association. The enthalpic and entropic contributions
to the free energy of binding were determined by measuring
the initial binding of RNA to the enzyme as a function of tem-
perature (Fig. 3A). The RNA binding reaction was shown to
be exothermic at 25 C with a high enthalpy of association,
DH = 20.6 kJ/mol. Analysis of a van’t Hoﬀ plot for the inter-
action between RNA and the WNV RNA triphosphatase
(Fig. 3A) revealed that the TDS value for the binding reaction
was 9.2 kJ/mol, clearly indicating that the initial RNA binding
step is primarily driven by enthalpy. Furthermore, the binding
reaction is clearly favorable with the resultant DS0 = 30 J/
mol K.
An important component of protein–ligand binding energet-
ics is the interaction of protein residues with the electrostatic
ﬁeld of the ligand. The salt-dependence of the NS3–RNA
interaction provides information about the contribution of
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Fig. 3. Characterization of the interaction between RNA and NS3. (A) A van’t Hoﬀ plot for the interaction between RNA and NS3 is shown. The
eﬀect of temperature on the association constant was evaluated at pH 7.0. (B) The eﬀect of increasing ionic strength on the apparent dissociation
constant of NS3 for RNA was investigated. Increasing concentrations of KCl were added to the reactions to generate the desired ionic strengths. (C)
Kinetic analysis of real-time binding of RNA to the NS3 protein. A 1 lM solution of the enzyme was incubated with 100 lM RNA. Emission was
monitored for 300 s at 338 nm, and excitation was performed at 290 nm. (D) Aﬃnity of the NS3 protein for RNA of 30 (j), 20 (), 15 (d), and 13
(s) nucleotides. Increasing amounts of RNA were added to a 1 lM solution of the enzyme in binding buﬀer (50 mM Tris–HCl and 50 mM KOAc,
pH 7.5) and the emission spectrum was scanned from 310 to 440 nm upon excitation at 290 nm. A saturation isotherm can be generated from these
data by plotting the change in ﬂuorescence intensity at 338 nm as a function of added RNA.
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static interactions to the binding of RNA to the NS3 protein
was investigated by monitoring the salt-dependence of the
binding process. The experimentally observed equilibrium con-
stant was clearly dependent on the ionic strength of the solu-
tion (Fig. 3B). In solution, nucleic acids are associated with
a layer of positive counterions, which neutralizes the high neg-
ative charge of the phosphodiester backbone [40]. These coun-
terions can be displaced by electrostatic interactions with
positively charged groups of the protein, leading to a depen-
dence of the binding reaction on salt concentration. As shown
in Fig. 3B, the RNA-enzyme interaction was attenuated at ele-
vated KCl concentrations. The equilibrium binding experi-
ments showed that the apparent Kd at 500 mM KCl was
40 lM, almost seven times higher than in absence of KCl.
Evaluation of the Gibbs energy due to electrostatic interac-
tions (DDGES) by extrapolation of the binding reaction to an
ionic strength of 1 M, the standard state where electrostatic
interactions are eﬀectively eliminated, revealed that 20.4% of
the binding energy is derived from electrostatic interactions.
The use of ﬂuorescence spectroscopy also allowed us to
monitor the kinetics of the initial RNA binding to the WNV
NS3 protein (Fig. 3C). The progress of the binding reaction
was followed for 60 s upon addition of saturating amountsof RNA. The results show that there is a rapid exponential de-
crease in ﬂuorescence intensity following the addition of RNA.
An apparent association rate of 47 lM1 s1 was estimated
from the data. Half-maximal quenching was observed at
approximately 9 s, while maximal quenching was achieved
after 300 s of incubation with RNA and remained constant
thereafter. The exponential decrease in ﬂuorescence observed
following the addition of RNA was not due to photobleaching,
as similar results were obtained when the protein was incu-
bated away from the light source.
Finally, in order to determine the minimal RNA binding site
size, ﬂuorescence spectroscopy assays were performed with 5 0
hydroxy-terminated RNA substrates ranging from 10 to 30
nt (Fig. 3D). Our data indicate that the enzyme could bind eﬃ-
ciently to RNA substrates of 20, 15, and 13 nt in length (Kd
values of 6, 5, and 4 lM, respectively). However, RNA sub-
strates of 11 or 12 nt were bound very weakly by the enzyme,
and no accurate binding constants could be eﬃciently and
repeatedly determined. No binding could be observed for
RNA substrates of 10 nt or less. Based on these data, we con-
clude that the minimal RNA binding site size of NS3 is 13 nt.
It should also be noted that the addition of various concentra-
tions of metal ions (Mg2+ or Mn2+) did not aﬀect the RNA
binding properties of the NS3 protein. Similar binding
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Fig. 5. Binding of ANS to the NS3 protein during urea denaturation.
The NS3 protein was incubated in the absence (j) or presence of
100 lMRNA (h), and unfolded with various concentrations of urea at
22 C for 1 h. Fluorescence emission was monitored after ANS
addition (50 lM) at an excitation wavelength of 380 nm. The
integrated ﬂuorescence area between 400 and 600 nm was evaluated.
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pic and entropic contributions) were determined when experi-
ments were performed in the presence of increasing
concentrations of metal ions up to 50 mM.
3.5. Eﬀect of RNA binding on the structure of NS3
Far-UV circular dichroism (CD) spectra can provide useful
information on the secondary structural features of a protein
while the CD spectra in the near-UV region reﬂect the environ-
ments of the aromatic amino acid side chains, giving informa-
tion about the tertiary structure of a protein. In an eﬀort to
determine if the binding of the RNA to the NS3 protein results
in the modiﬁcation of the NS3 structure, far- and near-UV CD
spectra were recorded both in the presence and the absence of
the 5 0 hydroxy-terminated RNA substrate of 30 nucleotides.
Analysis of the far-UV spectrum of unliganded NS3 suggests
that the secondary structure of the protein contains 37% a-he-
lix and 26% b-sheet (Fig. 4A) [41]. Examination of the far-UV
CD spectrum of the NS3–RNA complex revealed that the
binding of RNA to the protein does not induce a signiﬁcant
modiﬁcation of the secondary structure of the protein (data
not shown). Thus, the far-UV CD spectra suggest that the
NS3 protein maintains a comparably ordered secondary struc-
ture following the binding of RNA.
Analysis of the near-UV CD spectra of the NS3 protein in
both the absence and presence of RNA was performed from
250 to 300 nm. A signiﬁcantly increased molar ellipticity is ob-
served over the 265–280 nm region when the protein is incu-
bated with RNA (Fig. 4B). Furthermore, the NS3–RNA
complex displays negative ellipticity in the 280–320 nm region
in comparison to ellipticity observed for the unliganded NS3
protein. These dramatic changes in the near-UV CD spectra
clearly indicate that a conformational change occurs in the ter-
tiary structure of NS3 upon RNA binding. Overall, the CD
spectra suggest that the protein undergoes conformational
change upon the binding of RNA, although no radical modi-
ﬁcations of the overall protein architecture are occurring.
In order to gain additional insights into the structural mod-
iﬁcations that occur upon RNA binding, we investigated the
binding of a structural ﬂuorescent reporter to the enzyme.
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Fig. 4. Structural consequences of RNA binding to the NS3 protein. (A) A c
protein (8 lM). The spectrum was recorded from 200 to 350 nm, and the ave
recorded for the unliganded NS3 protein (black line), and the protein bound to
was induced by incubating the NS3 protein (8 lM) with 100 lM RNA. T
wavelength scans is presented.was evaluated by measuring the binding of ANS (1-anilino-
8-naphtalenesulfonate) to the protein. ANS is a reporter of ex-
posed hydrophobic surfaces on proteins that binds with high
aﬃnity to hydrophobic patches, which results in an enhance-
ment of ANS intrinsic ﬂuorescence [42]. Our data revealed that
the unliganded NS3 protein binds very weakly to ANS, prob-
ably reﬂecting limited hydrophobic regions at the surface of
the protein (Fig. 5). No signiﬁcant modiﬁcation of the ANS
ﬂuorescence is observed when the protein is incubated in the
presence of saturating concentrations of the 5 0 hydroxy-termi-
nated RNA substrate of 30 nucleotides (Fig. 5). Overall, these
data indicate that the conformational change that is observed
upon RNA binding does not involve signiﬁcant hydrophobic
exposure on the NS3 surface.
3.6. Eﬀect of RNA binding on the stability of NS3
Circular dichroism spectroscopy assays were performed to
investigate whether or not the binding of RNA could increase
the stability of the WNV NS3 protein. Thermal denaturation.
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Table 1
Thermodynamic unfolding parameters of the WNV NS3 protein
measured by thermal denaturation
Protein Tm (C) DHVH (kJ/mol) DS (kJ/mol/K)
NS3 43.68 192.8 0.61
NS3 Æ RNA 44.34 319.8 1.0
The thermodynamic parameters of unfolding DHVH (van’t Hoﬀ en-
thalpy of denaturation) and DS (entropy of denaturation) were
determined by thermal denaturation of the NS3 enzyme bound to
various substrates. Temperature-induced denaturations were moni-
tored by circular dichroism spectroscopy at 222 nm.
874 I. Benzaghou et al. / FEBS Letters 580 (2006) 867–877assays were carried out from 4 to 110 C both in the presence
and absence of the 5 0 hydroxy-terminated RNA substrate of 30
nucleotides. As shown in Fig. 6A and B, the helical content
(222 nm) of the enzyme is decreased upon thermal denatur-
ation both for the unliganded protein and the protein bound
to RNA. Unfolding of the enzyme was therefore evaluated
by monitoring the changes in the a-helix content of the protein
(222 nm). The denaturation assays performed with the unli-
ganded NS3 protein revealed a monophasic unfolding curve,
suggestive of a two-state unfolding model. No intermediate
form could be detected during the unfolding process, and a
midpoint of thermal transition (Tm) of 43.68 C (Fig. 6C)
was determined. Addition of saturating concentrations of
RNA only resulted in a small shift of the Tm value to
44.34 C. Accordingly, evaluation of the thermodynamic
parameters of unfolding revealed similar values for the unli-Wavelength (nm)
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Fig. 6. Unfolding equilibrium of the NS3 protein. (A) Thermal
denaturation of the NS3 enzyme at a concentration of 8 lM. Circular
dichroism spectra were recorded from 200 to 260 nm at 20 (green), 30
(blue), 40 (red), 50 (yellow), 60 (cyan), and 70 C (purple). (B) Thermal
denaturation of the NS3 enzyme (8 lM) in the presence of 100 lM
RNA. Circular dichroism spectra were recorded from 200 to 260 nm at
20 (green), 30 (blue), 40 (red), 50 (yellow), 60 (cyan), and 70 C
(purple). (C) Thermal denaturation was recorded for the unliganded
NS3 protein (black line), and the protein incubated in the presence of
100 lM RNA (red line). Circular dichroism spectra were recorded at a
constant wavelength of 222 nm from 5 to 110 C at a protein
concentration of 8 lM.ganded NS3 protein or the protein bound to RNA (Table 1).
Overall, these results demonstrate that the binding of RNA
to the NS3 protein does not signiﬁcantly increase the structural
stability of the enzyme.4. Discussion
Analyses of protein–ligand interactions are a necessary
counterpart to high resolution structural studies for full com-
prehension of enzymatic reactions in a quantitative way. In
the present study, the use of ﬂuorescence spectroscopy and cir-
cular dichroism allowed us to determine both the thermody-
namic parameters and conformational changes that are
associated with the binding of RNA to the WNV NS3 protein.
While the thermodynamic parameters of the binding reaction
do not provide a complete picture of the binding activity, they
can suggest which features are likely to be important for the
interaction, and provide a framework to construct an accurate
model of the complex.
Deﬁning the interaction between the enzymes involved in
RNA capping and their ligands is critical to any understanding
of the role of these proteins. A key question at this point is how
do proteins involved in RNA capping bind to their RNA sub-
strates? The ﬂuorescence data reported in this study provide a
surprisingly simple picture of RNA binding to the WNV RNA
triphosphatase. All of the kinetic processes measured in this
work were adequately analyzed using single exponential rate
equations. In no case was there any evidence for another sig-
niﬁcant kinetic barrier during binding that would require the
use of a second exponential equation to satisfactorily ﬁt the
data. In evaluating the energetics of RNA binding, our study
leads to an increased understanding of the molecular basis of
substrate recognition by the WNV RNA triphosphatase.
Changes in both the magnitude and the sign of DH and DS,
in conjunction with structural data, can provide crucial infor-
mation about the structural alterations that accompany ligand
binding in terms of (1) changes in salvation state; (2) interac-
tions between ligand and protein, such as electrostatic and
hydrophobic interactions; and (3) changes in conformation/
dynamics induced by ligand binding. Our thermodynamic
analyses indicate that the initial association of RNA with the
NS3 protein is driven by a favorable enthalpy change. Favor-
able negative enthalpy changes are generally associated with
contributions from hydrogen bonds, van der Waal’s interac-
tions, or ionic interactions [43]. The importance of electrostatic
interactions for the binding of RNA to the NS3 protein was
further noted in our ﬂuorescence spectroscopy. The observed
reduction in RNA binding in the presence of salt is also a likely
cause for the reduction of the RNA triphosphatase activity
that is noted at high salt concentrations. This mode of RNA
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diﬀerent than the one recently determined for the yeast RNA
guanylyltransferase, the only other enzyme involved in RNA
capping for which the thermodynamic parameters of the
RNA binding reaction have been evaluated [36]. The studies
performed with the yeast guanylyltransferase clearly indicated
that the RNA binding reaction is dominated by a favorable
entropic eﬀect, with a minor contribution from a favorable en-
thalpy change [36]. These results suggested that hydrophobic
and stacking interactions play a more signiﬁcant role in the
formation of the yeast guanylyltransferase–RNA complex
compared with ionic contacts.
Our studies allowed us to determine key aspects involved
in the interaction between the WNV RNA triphosphatase
and RNA. The multifunctional vaccinia virus capping en-
zyme is the only viral enzyme involved in RNA capping
for which RNA binding studies have previously been per-
formed [44]. This protein harbors the catalytic sites for all
three enzymatic reactions involved in the capping of vaccinia
virus mRNAs (RNA triphosphatase, RNA guanylyltransfer-
ase, and RNA (guanine-7) methyltransferase). Using electro-
phoretic mobility shift assays it was estimated that the
minimal RNA binding site of the vaccinia enzyme was 20–
25 nucleotides, and that no particular 5 0 end structure was
required for binding [44]. As demonstrated in our binding as-
says, this last property is also shared by the WNV RNA tri-
phosphatase. Using ﬂuorescence spectroscopy, we
demonstrated that the minimal RNA binding site size of
the NS3 protein is 13 nt. One of the novel aspects of our
binding studies is the analysis of the conformational changes
that occur following the interaction of NS3 with RNA. Con-
formational changes in proteins are frequently critical for
their function and/or regulation. We have looked for confor-
mational changes in NS3 upon the binding of RNA using
spectroscopic approaches. Our data indicate that a confor-
mational change is occurring upon binding of the RNA to
the NS3 architecture. This is in contrast to the yeast RNA
triphosphatase enzyme which possesses a preformed activeFig. 7. Three-dimensional model of the WNV NS3 protein. (A) Ribbon rep
NS3 protein. The model was generated with the Deep View program [28]. (
shown.site, and where major domain rearrangements are not needed
to form a catalytically active site [37]. Additional diﬀerences
between the two enzymes include the metal ion requirements
and the three-dimensional structure of the proteins. In con-
trast to the WNV NS3 protein, the yeast RNA triphospha-
tase, has been shown to require divalent cations for its
activity, and the active site of the enzyme is located in a tun-
nel-like structure composed of eight antiparallel b strands
[22,29].
The RNA triphosphatase component of the WNV capping is
an attractive target for the development of antiviral drugs that
would selectively interfere with the capping of the viral
mRNAs while leaving the host capping enzymes unaﬀected.
This suggestion is based on the fact that the catalytic mecha-
nism and structure of the WNV RNA triphosphatase is com-
pletely diﬀerent from the human enzyme. Given that
inorganic phosphate is the product of the RNA triphosphatase
reaction, we surmised that phosphate derivatives might be eﬃ-
cient competitors. Interestingly, the use of product-derived
inhibitors has recently been shown to be eﬃcient for the design
of both HCV and WNV protease inhibitors [45,46]. Using such
an approach we demonstrated that tripolyphosphate is a very
potent inhibitor of the WNV RNA triphosphatase activity.
This inhibitor binds more tightly to the enzyme active site than
the triphosphate-terminated RNA substrate. Tripolyphos-
phate, with its ability to interact with the WNV RNA triphos-
phatase, has the potential to serve as a template for the
development of more potent inhibitors. Interestingly, tripoly-
phosphate has previously been shown to inhibit the RNA tri-
phosphatase activity from Schizosaccharomyces pombe,
Trypanosoma brucei, and Chlorella virus [47–49]. Analysis of
the WNV NS3 protein structure using computer algorithms re-
veals that both the Hepatitis C virus and WNV NS3 protein
adopt very similar conformations (Fig. 7). The high level of
similarity between the NS3 protein of diﬀerent members of
the Flaviviridae family [8] suggests that tripolyphosphate might
display broad spectrum inhibitory activity against the other
members of the family. Future analysis of the interaction be-resentations of the predicted three-dimensional structure of the WNV
B) The structure of the hepatitis C virus NS3 helicase domain is also
876 I. Benzaghou et al. / FEBS Letters 580 (2006) 867–877tween RNA triphosphatase inhibitors and the enzyme will also
undoubtedly shed light on the chemistry of the RNA capping
reaction.
The crystal structure coordinates of the hepatitis C virus
NS3 protein [50] were used to generate a homology model of
the WNV NS3 protein. Analysis of the predicted structural
features revealed signiﬁcant overall structural similarities be-
tween the two enzymes (Fig. 7). Interestingly, the RNA tri-
phosphatase of ﬂaviviruses appears to belong to a new
family of RNA triphosphatases that use the active center of
a classical helicase to mediate their RNA triphosphatase activ-
ity. The hypothesis of one active center shared by NTPase/heli-
case and RNA triphosphatase is not novel for RNA viruses. A
recombinant k1 protein from reovirus was previously shown to
possess both NTPase/helicase and RNA triphosphatase activ-
ities [31]. Competitive binding experiments revealed that both
activities occur at a common active site [31]. The replicase pro-
tein of the bamboo mosaic virus (Alphaviridae) also displays
both NTPase/helicase and RNA triphosphatase [51]. More re-
cently, a recombinant NS3 protein from Dengue virus, a mem-
ber of the Flaviviridae family, was also shown to harbor both
these activities [33]. Elegant mutational studies performed both
with the bamboo mosaic and Dengue viruses also conﬁrmed
that the RNA triphosphatase reaction requires an intact
NTPase/helicase activity [33,51]. We believe that the design
of the WNV NS3 protein model has important implications
for the design of drugs and small molecule inhibitors of poten-
tial therapeutic value. The high level of similarity between the
WNV NS3 protein [8] and the corresponding protein of other
ﬂaviviruses suggest that the model may be broadly applicable
to the other members of the family.
The metal ion requirements for the RNA triphosphatase
activity mediated by the NS3 protein of ﬂaviviruses has been
the subject of intense debate during the past few years. The
activity has been shown to be independent of magnesium ions
for both the full-length recombinant NS3 protein of Dengue
virus and the 50 kDa C-terminal region of the WNV NS3 pro-
tein released with subtilisin from the membranes of infected
cells [13,32]. Our assays also indicate that the RNA triphos-
phatase activity of the recombinant WNV NS3 protein is mag-
nesium-independent. In fact, both magnesium and manganese
have an inhibitory eﬀect on the RNA triphosphatase activity.
Based on the results of our RNA binding studies, we demon-
strated that the presence of metal ions does not signiﬁcantly in-
hibit the binding of RNA to the enzyme. The fact that the
ﬂaviviral enzymes do not require a metal cofactor for their
RNA triphosphatase activity is somehow surprising given that
they require magnesium for their NTPase/helicase activity, and
that both activities share a common active site [52]. Metal ions
have the potential of fulﬁlling multiple functional roles in
phosphohydrolase catalysis, including: (i) increasing the aﬃn-
ity of the enzyme for the RNA substrate; (ii) increasing the sta-
bility of the protein; (iii) being directly involved in catalysis by
promoting the activation of nucleophiles; and (iv) stabilizing
the transition state. It is clear that the phosphohydrolase reac-
tion requires a very precise alignment between the residues in
the active site of the protein, the substrate, and the metal ion
cofactor. The RNA triphosphatase of S. cerevisiae constitutes
a good example of this complex metal ion requirement. For
this enzyme, the hydrolysis of RNA triphosphate ends is acti-
vated by magnesium, but not by manganese or cobalt, while
the NTPase activity is supported by manganese and cobalt,highlighting the importance of the metal ion cofactors in catal-
ysis [22]. The metal ions probably modify the coordination
geometry, or induce local conformational perturbations in
the active site residues that ultimately inﬂuence substrate spec-
iﬁcity [45]. A similar situation is most likely occurring for the
WNV NS3 protein. Although the complete understanding of
the mechanisms underlying the NS3-mediated phosphohydro-
lase is still incomplete, characterization of the biochemical
properties of the protein should provide the basis for further
studies in this direction.
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